Objectives To compare the sensitivity of 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology (EULAR/ACR) classification criteria against 1997 ACR criteria for ...

Background: The McDonald criteria include MRI evidence for dissemination in space and dissemination in time for the diagnosis of multiple sclerosis in young adult patients who present with clinically ...

Systemic lupus erythematosus (SLE) is a heterogenic connective tissue disease with a broad spectrum of clinical and laboratory manifestations. Due to this heterogeneity, SLE remains challenging to ...

In addition to these symptoms, systemic sclerosis can affect internal organs, such as the lungs and kidneys, with serious consequences. We know that immune dysregulation causes vascular damage and ...

"The results were intriguing," explains Masayuki Nishide, senior author. "We identified a specific subset of immune cells, the EGR1-expressing subpopulation of CD14+ monocytes, that were clearly ...

Objective To analyse comorbidity and healthcare utilisation in individuals with SLE.Methods A cohort of individuals with incident SLE diagnosis in 2016 were investigated using claims data from a ...

Researchers at Baylor College of Medicine have made significant strides in understanding systemic sclerosis (SSc), a complex autoimmune disease, through a new study that combines integrative exome ...

Systemic sclerosis (SSc) is a severe autoimmune disease with complex genetic causes. Some genetic contributors have been identified, but others remain unknown, which has impeded development of ...

Background Systemic sclerosis (SSc) is a heterogeneous disease with frequently associated interstitial lung disease (SSc-ILD). We aimed to determine the prognostic potential of phenotyping patients ...

Send comments and news tips to news@medscape.net. Cite this: Upadacitinib Outperforms Mycophenolate in Treating Systemic Sclerosis-Associated ILD - Medscape - June 13, 2025.